Zakara Biotechnology Fund LP — Form D
Zakara Biotechnology Fund LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-04-15. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-04-15
- Form: D
- Accession: 0000919574-25-002456
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Security types: equity, fund interests
- SEC file number: 021-543714
Issuer
- Name: Zakara Biotechnology Fund LP
- CIK: 0002058789
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 300 PARK AVENUE 2ND FLOOR, SUITE 201, NEW YORK, NY, 10022
- Phone: 646 419 8761
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Janet Okogbaa | Executive Officer | New York, NY |
| - Zakara Biotechnology Fund GP LLC | Executive Officer | New York, NY |
| - Zakara Capital LLC | Executive Officer | New York, NY |
| Janet Okogbaa | Promoter | New York, NY |
| - Zakara Biotechnology Fund GP LLC | Promoter | New York, NY |
| - Zakara Capital LLC | Promoter | New York, NY |
| Janet Okogbaa | Related Person | New York, NY |
Other filings by this issuer (1)
More